Cutoff conc, zg/L CK-MB During the study period, 9 patients had adverse outcomes.
(95% Cl, 1.5-29) and 8.8 (1.9-41), respectively.
The results obtained with these lower cutoff concentrations were more predictive than those based on the preestablished AM! cutoff values of 5.0 and 2.5 .tg/L, respectively.
These odds ratios show that poor outcome was significantly more frequent in the high-cTnI group than in the lowcTnI group. Although also prognostic in this study, the utility of CK-MB for risk stratification remains questionable, given the conflicting results of previous studies [4] . cTnI may have more promise because it has higher specificity for heart damage than does CK-MB [9] . Odds ratios for cTnI in this study were similar to those in our previous study of cTnT [10] . Whether or not cTn! is equal to or better than cTnT remains to be determined. Our current in-house quality-control materials are made from fresh whole blood and are stored frozen at -20 #{176}C. To evaluate the reconstituted commercial controls as a potential alternative to our in-house materials, we compared the long-term quality-control performances of both sets of materials when stored together at -20 #{176}C, rather than at the -70 #{176}C used in the earlier study [1] .
We prepared the Lyphochek controls exactly as recommended [1] . Briefly, vials of lyophilized human blood (Lyphochek Levels 2 and 3) were reconstituted with deionized water, mixed, and allowed to stand for 30 mm. They were then diluted 1:11 in fresh 10 g/L ascorbic acid to give an ascorbated hemolysate [1] . We also prepared a more-dilute hemolysate suitable for direct addition to microtiter plates for microbiological assay. This was prepared by a further 1:40 dilution of the above hemolysate in 5 g/L sodium ascorbate.
The in-house controls (n = 4), having a range of folate values, were prepared by diluting fresh anticoagulated (EDTA) whole blood 1:11 into fresh 10 g/L ascorbic acid, mixing, and incubating at 37 #{176}C for 30 mm to allow complete deconjugation of folate polyglutamates.
Cell debris was removed by centrifugation, and the supernatant liquid was filtered through a 0.2-gm syringe filter (Nalge, Rochester, NY The long-term performance of undiluted in-house controls (n = 4) was good, with individual reproducibility (CV) over the 16 months of 5.2%, 5.6%, 2.3%, and 5.4%. Equivalent reproducibility data for diluted in-house materials assayed in parallel were 3.5%, 3.4%, 4.3%, and 4.0%, respectively.
We continued to assay these diluted hemolysates weekly for a further 10 months and obtained good reproducibility over the full 26-month period (CVs of 3.9%, 7.1%, 3.6%, and 5.5%, respectively).
On the other hand, analysis of both the undiluted and diluted commercial control hemolysates was discontinued after the initial 16 months because of poor reproducibility (CV >50%) due to folate instability (Fig. 1) .
The whole-blood folate concentrations of the in-house (n = 3) and commercial controls stored and assayed weekly in parallel are shown in Fig. 1 These preparations were stored at both -20 #{176}C and -70 #{176}C for 10 months and assayed weekly in parallel.
Analysis of the monthly means (n = 10) confirmed the poor reproducibility of both undiluted and diluted ascorbated hemolysates at -20 #{176}C, whereas at -70 #{176}C the identical aliquots remained quite stable, whether stored undiluted (CVs of 3.6% and 3.8%) or diluted (1.8% and 5.5%).
The relative instability of folates at -20 #{176}C in reconstituted commercial hemolysates as compared with fresh inhouse whole-blood hemolysates in ascorbate is disconcerting and may relate to analyte supplementation by the manufacturers so as to achieve target values. Lyphochek controls are designed to be stored lyophilized at 4 #{176}C, and the manufacturer makes no claims for the stability of ascorbated hemolysates. They do state, however, that the reconstituted frozen material (at -10 #{176}C to -20 #{176}C) will be stable for 30 days; we did not evaluate that average condition.
The controls gave excellent reproducibility previously when stored at -70 #{176}C [1] , and our study confirms that. The results presented here also emphasize the importance of assessing the performance of all such controls before using them. #{176} Analyzed in duplicate with mntraassay CV = 3.5% and mnterassay CV = 5.5%, under conditions identical to those used for thiosulfate assay.
* Mean ± SE (and range).
#{176} Taken from ref.
11. In that study, the difference between 24-h urines and early-morning specimens was much smaller than the interindividual variation. 
